2nd Oligonucleotide-Based Therapeutics Summit
December 8 - 10, 2026 - MA USHanson Wade
info@hansonwade.com
Phone:+44 (0)20 3141 8700
Maximizing the Affinity, Specificity, and Efficacy of Oligonucleotide Therapeutics through Smarter Chemistry and Tissue- and Cell-Specific Delivery to Translate Innovation into Clinical Success Time: 8:00 AM - 6:00 PM